EuBiologics disclosed June 5 that it had signed a contract with UNICEF to supply its oral cholera vaccine, EubiVac.
The contract is valued at 13.26 billion won (approximately $8.68 million), equivalent to 8.89 percent of the company's 2025 sales.
The contract runs through Aug. 3.
jiyoon436@heraldcorp.com
